Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Ordinary Shares, par value GBP 0.003 per share
-
Shares outstanding
-
792,553,191
-
Total 13F shares
-
1,243,651
-
Share change
-
-794,650
-
Total reported value
-
$4,079,000
-
Price per share
-
$3.28
-
Number of holders
-
10
-
Value change
-
-$2,385,808
-
Number of buys
-
1
-
Number of sells
-
9
Institutional Holders of Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) as of Q4 2019
As of 31 Dec 2019,
Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,243,651 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, Delphi Management Partners VIII, L.L.C., PERCEPTIVE ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, CSS LLC/IL, STATE STREET CORP, UBS Group AG, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, and Rockefeller Capital Management L.P..
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.